(PDF) Diagnosis and Monitoring for Light Chain Only and

Diagnosis and Monitoring for Light Chain Only and Oligosecretory Myeloma Using Serum Free Light Chain Tests

Clinical Lymphoma, Myeloma and Leukemia - United States

doi 10.1016/j.clml.2017.03.172

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

February 1, 2017

Authors

Jennifer Heaney

Jane Birtwistle

Publisher

Elsevier BV

Related search

Monitoring of Light Chain Myeloma - Time for a Change

British Journal of Haematology

English

Prognostic Utility of Serum Free Light Chain Ratios and Heavy-Light Chain Ratios in Multiple Myeloma in Three PETHEMA/GEM Phase III Clinical Trials

Multidisciplinary

English

Increased Serum Free Light Chains Precede the Presentation of Immunoglobulin Light Chain Amyloidosis

Journal of Clinical Oncology

Cancer Research

English

Responses in Multiple Myeloma Should Be Assigned According to Serum, Not Urine, Free Light Chain Measurements

Cancer Research

English

Serum Free Light Chain Quantitative Assays: Dilemma of a Biomarker

Journal of Clinical Laboratory Analysis

Medical Laboratory Technology

Clinical Biochemistry

Occupational Health

English

Serum Free Immunoglobulin Light Chain Evaluation as a Marker of Impact From Intraclonal Heterogeneity on Myeloma Outcome

English

The Use of Serum Free Light Chain Dimerization Patterns Assist in the Diagnosis of AL Amyloidosis

British Journal of Haematology

English

Genomic Aberrations and Survival of Patients With Light-Chain-Only Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Transplantation

English

Type I Gaucher Disease Following Chemotherapy for Light Chain Multiple Myeloma

Internal Medicine

Internal Medicine

English